What is Q Surgical?
Headquartered in Sausalito, California, Q Surgical operates as a specialized medical device distribution entity. The company serves as a vital intermediary between high-end medical device manufacturers and clinical institutions, with a primary focus on neurosurgery, spine surgery, and ophthalmic surgery. By prioritizing deep technical knowledge and a commitment to clinical outcomes, Q Surgical has carved out a niche in the healthcare ecosystem. Their business model is predicated on the seamless integration of innovative surgical technologies into hospital workflows, ensuring that healthcare providers have access to the most practical and effective tools for patient care. The firm's emphasis on purposeful solutions and professional engagement distinguishes it from traditional logistics-heavy distributors, positioning it as a value-added partner in the surgical theater.
How much funding has Q Surgical raised?
Q Surgical has raised a total of $406K across 2 funding rounds:
Debt
$150K
Debt
$256K
Debt (2020): $150K with participation from PPP
Debt (2021): $256K led by PPP
Key Investors in Q Surgical
PPP
Public-Private Partnership
What's next for Q Surgical?
With the recent capital injection, Q Surgical is well-positioned to expand its footprint in the competitive medical device landscape. The strategic allocation of these funds will likely focus on enhancing supply chain resilience, broadening the portfolio of specialized surgical products, and deepening relationships with key clinical stakeholders. As the company navigates its late-stage development, the focus will shift toward operational efficiency and market penetration in high-growth surgical segments. By leveraging its established network and the recent financial backing, Q Surgical aims to further solidify its reputation as a premier distribution partner, driving innovation and improving the standard of care for patients requiring complex surgical interventions.
See full Q Surgical company page